Related references
Note: Only part of the references are listed.Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies
Michelle D. Reid et al.
ENDOCRINE PATHOLOGY (2014)
Phosphohistone H3 and Ki-67 Labeling Indices in Cytologic Specimens from Well-Differentiated Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas: A Comparative Analysis Using Automated Image Cytometry
Adele D. Fung et al.
ACTA CYTOLOGICA (2013)
Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate
Chad M. McCall et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Pathology Reporting of Neuroendocrine Tumors: Essential Elements for Accurate Diagnosis, Classification, and Staging
David S. Klimstra
SEMINARS IN ONCOLOGY (2013)
Comparison of Methods for Proliferative Index Analysis for Grading Pancreatic Well-Differentiated Neuroendocrine Tumors
Pamela P. Goodell et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Ki67 Labeling Index in Neuroendocrine Tumors of the Gastrointestinal and Pancreatobiliary Tract To Count or Not to Count Is Not the Question, But Rather How to Count
Volkan Adsay
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System A Comparison of Digital Image Analysis With Manual Methods
Laura H. Tang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set
David S. Klimstra et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Computer-assisted pathological immunohistochemistry scoring is more time-effective than conventional scoring, but provides no analytical advantage
Chee Wee Ong et al.
HISTOPATHOLOGY (2010)
NANETS Treatment Guidelines Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Matthew H. Kulke et al.
PANCREAS (2010)
The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs) Well-Differentiated NETs of the Distal Colon and Rectum
Lowell B. Anthony et al.
PANCREAS (2010)
The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum
J. Philip Boudreaux et al.
PANCREAS (2010)
Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors
Anne Couvelard et al.
MODERN PATHOLOGY (2009)
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: Results of a phase II study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Share Paper
